-
ArticlePublication 2019Valuing Mortality Risk Reductions
This article and the accompanying working paper[1] review the literature and develop recommendations for valuing …
This article and the accompanying working paper[1] review the literature and develop recommendations for valuing mortality risk reductions in benefit-cost analyses that address low- and middle-income countries. Increasing life expectancy is a major goal of many policies implemented around the world. As a result, the value of reducing mortality risks has been extensively studied and several organizations have developed recommendations for estimating these values. However, both the recommendations and the underlying research primarily address high-income…
Health/Medicine | Preferences/Values | Priority Setting/Ethics | Health Outcomes | Decision Analysis | Benefit-Cost Analysis | Social Determinants | Policy/Regulation | Economics/Finance | Global | Critical Thinking/Analysis -
Online LearningVideo, Teaching Resource 2020Valuing Statistical Lives: Concepts, Current Practices, and Challenges
Many policies aim to improve longevity, decreasing the risk of death in each year, and …
Many policies aim to improve longevity, decreasing the risk of death in each year, and the value of these risk reductions often dominate the estimated benefits of risk regulations and other policies. This value is often expressed as the value per statistical life (VSL), a term that is widely misunderstood. It is not the value that the analyst, the government, or the individual places on saving an identified life with certainty. Instead, it reflects individuals’…
Health/Medicine | Benefit-Cost Analysis | Policy/Regulation | Climate/Environment | Global -
Working PaperPublication 2018Valuing Nonfatal Health Risk Reductions
This paper explores approaches for valuing nonfatal risk reductions associated with policy choices in low- …
This paper explores approaches for valuing nonfatal risk reductions associated with policy choices in low- and middle-income countries. The approach for valuation ideally would be based on estimates of individuals’ willingness to pay for changes in their own risks. However, high quality valuation research is not available for many nonfatal conditions even in high-income settings. Typically, two approaches are used either alone or in combination as rough proxies. The first involves applying an estimate of…
Health/Medicine | Preferences/Values | Priority Setting/Ethics | Health Outcomes | Decision Analysis | Benefit-Cost Analysis | Social Determinants | Policy/Regulation | Economics/Finance | Global | Critical Thinking/Analysis
3 Shown
General Resources
Teaching Resources
Collections
Learner Level
Teaching Topic